Agency
Complete Care Community Health Center, INC
Complete Care Community Health Center, INC was paid $72.50M by Medicaid between Jan 2018 and Dec 2024, across 169 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 98% of everything it billed.
33Billing provider infoCOMPLETE CARE COMMUNITY HEALTH CENTER, INC
LOS ANGELES, CA 90033
LOS ANGELES, CA 90033
33aNPI1215113964assigned 01/11/2008
33bProvider typePACE Provider Organization
28Total paid$72.50M
24GClaims1,346,460
24DCodes billed169
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other PACE Provider Organization providers in California
Rank by total paid#1 of 17
Median peer was paid$240.00
This provider vs. median302,083×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 47,140 | $4.71M | |
| 2019 | 99,766 | $7.06M | |
| 2020 | 178,271 | $10.16M | |
| 2021 | 225,716 | $12.47M | |
| 2022 | 215,501 | $10.69M | |
| 2023 | 264,312 | $13.86M | |
| 2024incomplete | 315,754 | $13.56M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 98% | 362,899 | 266,835 | $70.70M |
| G0467 | Community health center visit, returning patientFederally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | <1% | 9,323 | 6,772 | $321K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 92,234 | 56,785 | $266K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | <1% | 155,309 | 98,517 | $253K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | <1% | 54,860 | 36,024 | $218K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 2,478 | 1,967 | $150K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | <1% | 7,338 | 5,047 | $90K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | <1% | 7,959 | 5,218 | $57K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 1,296 | 980 | $43K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 12,793 | 9,347 | $33K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 1,104 | 802 | $27K |
| G0511 | Rural health clinic or federally qualified health center (rhc or fqhc) only, general care management, 20 minutes or more of clinical staff time for chronic care management services or behavioral health integration services directed by an rhc or fqhc practitioner (physician, np, pa, or cnm), per calendar month | <1% | 1,572 | 1,571 | $26K |
157 more codes
| A4267 | Contraceptive supply, condom, male, each | <1% | 2,384 | $26K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 5,580 | $21K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 2,125 | $18K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 10,185 | $17K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 6,313 | $17K |
| 92551 | <1% | 29,064 | $16K | |
| G2025 | Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only | <1% | 1,006 | $15K |
| 99205 | Prolong outpt/office vis | <1% | 439 | $14K |
| 96367 | <1% | 1,069 | $13K | |
| 20552 | <1% | 2,447 | $13K | |
| H1001 | Prenatal care, at-risk enhanced service; antepartum management | <1% | 16,268 | $11K |
| 20611 | <1% | 384 | $11K | |
| 20610 | <1% | 2,191 | $11K | |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | <1% | 14,466 | $10K |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 5,391 | $7K |
| 99000 | <1% | 60,013 | $7K | |
| 90686 | <1% | 5,674 | $6K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 32,199 | $6K |
| G0466 | Community health center visit, new patient | <1% | 189 | $6K |
| J3490 | Unclassified drugs | <1% | 119 | $6K |
| J7327 | Hyaluronan or derivative, monovisc, for intra-articular injection, per dose | <1% | 18 | $5K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 8,578 | $5K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 5,745 | $4K |
| H1002 | Prenatal care, at risk enhanced service; care coordination | <1% | 1,218 | $4K |
| 90715 | <1% | 1,419 | $3K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 5,576 | $3K |
| 90651 | <1% | 1,886 | $3K | |
| H1003 | Prenatal care, at-risk enhanced service; education | <1% | 8,492 | $3K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 17,260 | $2K |
| H2000 | Comprehensive multidisciplinary evaluation | <1% | 6,252 | $2K |
| 99173 | <1% | 28,988 | $2K | |
| 93000 | <1% | 1,427 | $2K | |
| 81025 | <1% | 5,534 | $2K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 4,719 | $2K |
| S5000 | Prescription drug, generic | <1% | 196 | $2K |
| 97803 | <1% | 8,363 | $2K | |
| 90670 | <1% | 5,112 | $1K | |
| 96156 | <1% | 12,121 | $1K | |
| 90734 | <1% | 952 | $1K | |
| 81002 | <1% | 62,303 | $1K | |
| 99401 | <1% | 8,435 | $1K | |
| 90619 | <1% | 391 | $1K | |
| 90633 | <1% | 1,981 | $927.48 | |
| 90621 | <1% | 574 | $873.00 | |
| S4993 | Contraceptive pills for birth control | <1% | 38 | $864.00 |
| 90698 | <1% | 1,245 | $783.00 | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 1,942 | $725.27 |
| 90677 | <1% | 337 | $684.62 | |
| 59425 | <1% | 195 | $666.58 | |
| 90671 | <1% | 957 | $652.50 | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 610 | $640.40 |
| 99381 | <1% | 1,011 | $607.78 | |
| S9452 | Nutrition classes, non-physician provider, per session | <1% | 3,659 | $523.12 |
| 59430 | <1% | 471 | $469.34 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 795 | $451.31 |
| 97802 | <1% | 3,272 | $447.14 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,033 | $441.45 |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 676 | $427.03 |
| 99497 | <1% | 81 | $381.97 | |
| 90710 | <1% | 433 | $378.00 | |
| 96402 | <1% | 287 | $351.56 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 685 | $348.04 |
| 90656 | <1% | 306 | $334.91 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 262 | $317.88 |
| 96415 | <1% | 84 | $300.83 | |
| 90680 | <1% | 2,164 | $297.00 | |
| 90744 | <1% | 569 | $288.00 | |
| 90620 | <1% | 99 | $283.00 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 612 | $273.58 |
| 99385 | <1% | 189 | $252.65 | |
| 99384 | <1% | 234 | $246.79 | |
| 90697 | <1% | 931 | $225.00 | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 82 | $198.40 |
| 20605 | <1% | 16 | $185.01 | |
| 99403 | <1% | 2,712 | $168.22 | |
| 90648 | <1% | 2,351 | $153.00 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,530 | $148.79 |
| 85018 | <1% | 7,817 | $141.73 | |
| 99386 | <1% | 45 | $136.80 | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 411 | $124.11 |
| 96151 | <1% | 371 | $120.00 | |
| 99383 | <1% | 211 | $117.56 | |
| 90674 | <1% | 42 | $93.76 | |
| 88150 | <1% | 788 | $87.50 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 273 | $68.46 |
| 90716 | <1% | 177 | $54.00 | |
| 3077F | <1% | 2,565 | $51.96 | |
| 99242 | <1% | 572 | $47.20 | |
| 90707 | <1% | 182 | $36.00 | |
| 90696 | <1% | 71 | $36.00 | |
| 99382 | <1% | 13 | $27.00 | |
| 90723 | <1% | 1,129 | $27.00 | |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | <1% | 373 | $18.00 |
| 90700 | <1% | 174 | $18.00 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 552 | $12.59 |
| 90681 | <1% | 32 | $9.00 | |
| 90473 | <1% | 2,424 | $8.08 | |
| 86580 | <1% | 175 | $7.91 | |
| J1750 | Injection, iron dextran, 50 mg | <1% | 19 | $6.52 |
| S0197 | Prenatal vitamins, 30-day supply | <1% | 1,430 | $4.20 |
| 82962 | <1% | 3,734 | $1.80 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 13 | $0.70 |
| 3078F | <1% | 19,415 | $0.12 | |
| 3074F | <1% | 19,850 | $0.09 | |
| 3079F | <1% | 4,276 | $0.02 | |
| G8752 | Most recent systolic blood pressure < 140 mmhg | <1% | 9,817 | $0.01 |
| 1159F | <1% | 20,970 | $0.01 | |
| 3075F | <1% | 2,115 | $0.01 | |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | <1% | 2,429 | $0.01 |
| Z6414 | 0% | 5,520 | $0.00 | |
| G8753 | Most recent systolic blood pressure >= 140 mmhg | 0% | 1,423 | $0.00 |
| Z6308 | 0% | 2,934 | $0.00 | |
| Z6400 | 0% | 10,128 | $0.00 | |
| Z6304 | 0% | 9,322 | $0.00 | |
| Z6500 | 0% | 2,947 | $0.00 | |
| Z6208 | 0% | 2,456 | $0.00 | |
| 1160F | 0% | 4,943 | $0.00 | |
| 96158 | 0% | 872 | $0.00 | |
| 11721 | 0% | 76 | $0.00 | |
| Z6202 | 0% | 174 | $0.00 | |
| 99188 | 0% | 174 | $0.00 | |
| 96417 | 0% | 100 | $0.00 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 0% | 57 | $0.00 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 0% | 30 | $0.00 |
| 0502F | 0% | 65 | $0.00 | |
| 96152 | 0% | 72 | $0.00 | |
| 96159 | 0% | 14 | $0.00 | |
| H1000 | Prenatal care, at-risk assessment | 0% | 176 | $0.00 |
| 96153 | 0% | 44 | $0.00 | |
| Z6302 | 0% | 103 | $0.00 | |
| A4207 | Syringe with needle, sterile 2 cc, each | 0% | 13 | $0.00 |
| 99201 | 0% | 39 | $0.00 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 59 | $0.00 |
| Z6410 | 0% | 17,320 | $0.00 | |
| Z1034 | 0% | 21,003 | $0.00 | |
| Z6406 | 0% | 9,675 | $0.00 | |
| 3080F | 0% | 1,249 | $0.00 | |
| Z1032 | 0% | 2,172 | $0.00 | |
| Z6204 | 0% | 6,672 | $0.00 | |
| G9231 | Documentation of end stage renal disease (esrd), dialysis, renal transplant before or during the measurement period or pregnancy during the measurement period | 0% | 1,234 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 0% | 40 | $0.00 |
| 1111F | 0% | 3,163 | $0.00 | |
| Z1038 | 0% | 485 | $0.00 | |
| 88738 | 0% | 709 | $0.00 | |
| Z6404 | 0% | 577 | $0.00 | |
| G8755 | Most recent diastolic blood pressure >= 90 mmhg | 0% | 691 | $0.00 |
| 1126F | 0% | 281 | $0.00 | |
| 96150 | 0% | 34 | $0.00 | |
| G9664 | Patients who are currently statin therapy users or received an order (prescription) for statin therapy | 0% | 156 | $0.00 |
| 3008F | 0% | 102 | $0.00 | |
| 1170F | 0% | 41 | $0.00 | |
| 99243 | 0% | 50 | $0.00 | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 0% | 118 | $0.00 |
| 1101F | 0% | 15 | $0.00 | |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | 0% | 53 | $0.00 |
| 1125F | 0% | 281 | $0.00 | |
| 99241 | 0% | 54 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLENCHITSKY, DINA (CHIEF EXECUTIVE OFFICER)